Measles in France;La rougeole en France

Medecine/Sciences

Volumn 28, Issue 11, 2012, Pages 1003-1007

  Antona, Denise ^a   Baudon, Claire ^a   Freymuth, François ^b   Lamy, Mathieu ^a   Maine, Catherine ^a   Du Chatelet, Isabelle Parent ^a   Lévy Bruhl, Daniel ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; ADULT; CHILD; DIARRHEA; FRANCE; FRENCH GUIANA; GEOGRAPHIC MAPPING; GUADELOUPE; HUMAN; INCIDENCE; INFANT; MARTINIQUE; MEASLES; NEWBORN; OTITIS MEDIA; PRESCHOOL CHILD; REUNION; REVIEW; SUBACUTE SCLEROSING PANENCEPHALITIS; UTILIZATION REVIEW; VACCINATION; VIRUS ENCEPHALITIS; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DIARRHEA; ENCEPHALITIS, VIRAL; FRANCE; FRENCH GUIANA; GEOGRAPHIC MAPPING; GUADELOUPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MARTINIQUE; MEASLES; MEASLES VACCINE; OTITIS MEDIA; PNEUMONIA, VIRAL; REUNION; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINATION; YOUNG ADULT;

EID: 84870518231     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20122811023     Document Type: Review

References (17)

1. Strebel PM, Papania MJ, Dayan GH, Halsey NA. Measles vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines, 5th ed. St Louis: Saunders, 2008.
2. Wolfson LJ, Grais RF, Luquero FJ, et al. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol 2009;38:193-205.
3. Ministère de la santé et des solidarités. Plan d'élimination de la rougeole et de la rubéole congénitale en France 2005-2010. Disponible à http://www.sante.gouv. fr/IMG/pdf/plan-elimination-rougeole.pdf (consulté le 26 mai 2012).
4. Haut conseil de la santé publique. Le calendrier des vaccinations et les recommandations vaccinales 2012 selon l'avis du Haut conseil de la santé publique. Bull Epidemiol Hebd 2012;14-15:161-86.
5. Brown KE, Mulders MN, Freymuth F, et al. Appearance of a novel measles G3 strain in multiple european countries within a two month period, 2010. Euro Surveill 2011;16:19852.
6. Lévy-Bruhl D, Maccario D, Richardson S, Guérin N. Modélisation de la rougeole en France et conséquences pour l'âge d'administration de la seconde vaccination rougeole-oreillons- rubéole. Bull Epidemiol Hebd 1997;29:133-5.
7. Fonteneau L, Urcun JM, Kerneur C, et al. Couverture vaccinale des enfants âgés de 11 ans scolarisés en CM2, France, 2004-2005. Bull Epidemiol Hebd 2008;51-52:493-7.
8. Lepoutre A, Antona D, Fonteneau L, et al. Enquête nationale de séroprévalence des maladies infectieuses 2009-2010, 1ers résultats. 12es Journées nationales d'infectiologie, communication orale, Toulouse, 2011. Med Mal Inf 2011;41(suppl 1):6.
9. Parent du Chatelet I, Antona D, Freymuth F, et al. Spotlight on measles 2010: update on the ongoing measles outbreak in France, 2008-2010. Euro Surveill 2010;15:19656.
10. Yasunaga H, Shi Y, Takeuchi M, et al. Measles-related hospitalizations and complications in Japan, 2007-2008. Intern Med 2010;49:1965-70.
11. Filia A, Brenna A, Pana A, et al. Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003. BMC Public Health 2007;7:169.
12. Carbonne A, Hassani Y, Thiolet JM, et al. Signalements de cas de rougeoles en établissements de santé, reçus au CCLIN Paris-Nord de janvier 2009 à mars 2011. Bull Epidemiol Hebd 2011;34-35:385-7.
13. Cottrell S, Roberts RJ. Measles outbreak in Europe. Br Med J 2011;342d3724.
14. Steffens I, Martin R, Lopalco P. Spotlight on measles 2010: measles elimination in Europe: a new commitment to meet the goal by 2015. Euro Surveill 2010;15:19749.
15. Delaporte E, Richard JL, Wyler Lazarevic CA, et al. Ongoing measles outbreak, Geneva, Switzerland, January to March 2011. Euro Surveill 2011;16:19815.
16. Measles-United States, January-May 20, 2011. Morb Mortal Wkly Rep 2011;60:666-8.
17. Nokes DJ, Anderson RM. The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes. Epidemiol Infect 1988;101:1-20.